Papaverine is an
opium alkaloid used primarily in the treatment of visceral
spasm,
vasospasm (especially those involving the
heart and the
brain), and occasionally in the treatment of
erectile dysfunction. While it is found in the
opium poppy, papaverine differs in both structure and pharmacological action from the other opium alkaloids (
opiates). In 1979, a Food and Drug Administration Advisory Committee evaluated studies on papaverine and concluded that there was a lack of objective data to support the therapeutic use of papaverine for these conditions. Papaverine remains available despite the committee's recommendation that it be withdrawn from the market.
Uses
Papaverine is approved to treat spasms of the gastrointestinal tract,
bile ducts and
ureter and for use as a
cerebral and
coronary vasodilator in
subarachnoid hemorrhage (combined with
balloon angioplasty) and
coronary artery bypass surgery. Papaverine may also be used as a smooth muscle relaxant in
microsurgery where it is applied directly to blood vessels.
It is also commonly used in cryopreservation of blood vessels along with the other glycosaminoglycans and protein suspensions. Functions as a vasodilator during cryopreservation when used in conjunction with verapamil, phentolamine, nifedipine, tolazoline or nitroprusside.
Papaverine is also being investigated as a topical growth factor in tissue expansion with some success.
Mechanism
The in vivo mechanism of action is not entirely clear, but an inhibition of the
enzyme phosphodiesterase causing elevation of cyclic AMP levels is significant. It may also alter
mitochondrial respiration.
Impotence is a long-term complication of diabetes. It is due to dysfunction of the autonomic nerves that mediate the erection. An erection is produced when the parasympathetic nerves that innervate the penile arterioles release acetylcholine, vasoactive intestinal peptide (VIP), and nitric oxide (NO). These neurotransmitters produce vasodilation with increased blood flow into the erectile tissues of the penis. As the penis becomes engorged with blood, the penile veins become compressed, so that outflow is blocked. Diabetes can be complicated by autonomic neuropathy. The exact cause of the neuropathy is unknown, but may include direct toxic effects of high extracellular glucose, accumulation of sorbitol within the nerves, or poor blood supply to the nerves because of decreased NO release by blood vessel endothelial cells.
Papaverine has also been demonstrated to be a selective phosphodiesterase inhibitor for the PDE10A subtype found mainly in the striatum of the brain. When administered chronically to mice it produced motor and cognitive deficits and increased anxiety, but conversely may produce an antipsychotic effect.
Side effects
Frequent side effects of papaverine treatment include polymorphic
ventricular tachycardia, constipation, interference with
sulphobromophthalein retention test (used to determine hepatic function), increased
transaminase levels, increased
alkaline phosphatase levels,
somnolence, and
vertigo.
Rare side effects include flushing of the face, hyperhidrosis (excessive sweating), cutaneous eruption, arterial hypotension, tachycardia, loss of appetite, jaundice, eosinophilia, thrombopenia, mixed hepatitis, headache, allergic reaction, chronic active hepatitis, and paradoxical aggravation of cerebral vasospasm.
Formulations and trade names
Papaverine is available as a
conjugate of
hydrochloride,
codecarboxylate,
adenylate, and
teprosylate. It was also once available as a salt of
hydrobromide,
camsylate,
cromesilate,
nicotinate, and
phenylglycolate. The hydrochloride salt is available for intramuscular, intravenous, rectal and oral administration. The teprosylate is available in intravenous, intramuscular, and orally administered formulations. The codecarboxylate is available in oral form, only, as is the adenylate.
The codecarboxylate is sold under the name Albatran, the adenylate as Dicertan, and the hydrochloride salt is sold variously as Artegodan (Germany), Cardioverina (countries outside Europe and the United States), Dispamil (countries outside Europe and the United States), Opdensit (Germany), Panergon (Germany), Paverina Houde (Italy, Belgium), Pavacap (United States), Pavadyl (United States), Papaverin-Hamelin (Germany), Paveron (Germany), Spasmo-Nit (Germany), Cardiospan, Papaversan, Cepaverin, Cerespan, Drapavel, Forpaven, Papalease, Pavatest, Paverolan, Therapav (France), Vasospan, Cerebid, Delapav, Dilaves, Durapav, Dynovas, Optenyl, Pameion, Papacon, Pavabid, Pavacen, Pavakey, Pavased, Pavnell, Alapav, Myobid, Vasal, Pamelon, Pavadel, Pavagen, Ro-Papav, Vaso-Pav, Papanerin-hcl, Qua bid, Papital T.R., Paptial T.R., Pap-Kaps-150.
References
- SID 544606 -- PubChem Substance Summary. . National Center for Biotechnology Information.
- Papaverine Material Safety Data Sheet. .
- Unknown PAPAVERINE. Molécule(s) de base: PAPAVERINE. Biam. (2000). . (French)
- Unknown Who should not take papaverine?. papaverine Consumer Drug Information. Cerner Multum, Inc. (2004). .
- Unknown PAPAVERINE CHLORHYDRATE. Molécule(s) de base: PAPAVERINE. Biam. (1999). . (French)
- Liu, James K.; Couldwell, William T (2005). "Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage". Neurocritical Care 2 (2): 124–32. Fulltext options List of Library Holdings
- Takeuchi K, Sakamoto S, Nagayoshi Y, Nishizawa H, Matsubara J (2004). "Reactivity of the human internal thoracic artery to vasodilators in coronary artery bypass grafting". European Journal of Cardio-Thoracic Surgery 26 (5): 956–9. Fulltext options List of Library Holdings
- SID 149219 -- PubChem Substance Summary. . National Center for Biotechnology Information.
- Clyde BL, Firlik AD, Kaufmann AM, Spearman MP, Yonas H (1996). "Paradoxical aggravation of vasospasm with papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report". Journal of Neurosurgery 84 (4): 690–5.
- Molécule de base: PAPAVERINE. . Biam.
- Unknown PAPAVERINE TEPROSILATE. Molécule(s) de base: PAPAVERINE. Biam. (1999). . (French)
- Unknown PAPAVERINE CODECARBOXYLATE. Molécule(s) de base: PAPAVERINE. Biam. (1998). . (French)
- Unknown PAPAVERINE ADENYLATE. Molécule(s) de base: PAPAVERINE. Biam. (1998). . (French)
- SID 660773 PubChem Substance Summary. . National Center for Biotechnology Information.
- SID 660767 -- PubChem Substance Summary. . National Center for Biotechnology Information.
- THERAPAV (PRODUIT PUR) - Détail. . CSST - Service du répertoire toxicologique. (French)
- SID 660767 -- PubChem Substance Summary - Depositor-Supplied Synonyms: All. . National Center for Biotechnology Information.